Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1861 USD | -10.31% | +1.14% | +27.99% |
03/04 | North American Morning Briefing : Powell Awaited -2- | DJ |
28/03 | Galera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 7.91M 659M |
---|---|---|---|---|---|
Net income 2022 | -62M -5.17B | Net income 2023 | -59M -4.92B | EV / Sales 2022 | - |
Net Debt 2022 | 108M 9.01B | Net Debt 2023 | 134M 11.18B | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.65
x | P/E ratio 2023 |
-0.11
x | Employees | 7 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.8% |
1 day | -10.31% | ||
1 week | +1.14% | ||
Current month | +32.93% | ||
1 month | +21.24% | ||
3 months | +4.85% | ||
6 months | -17.69% | ||
Current year | +27.99% |
Managers | Title | Age | Since |
---|---|---|---|
Dennis P. Riley
FOU | Founder | - | 01/09/01 |
J. Sorensen
CEO | Chief Executive Officer | 67 | 01/12/01 |
Robert Beardsley
FOU | Founder | 63 | 01/09/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Beardsley
FOU | Founder | 63 | 01/09/01 |
Michael Powell
CHM | Chairman | 69 | 28/16/28 |
Kevin Lokay
BRD | Director/Board Member | 67 | 01/19/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.1861 | -10.31% | 2,268,564 |
25/24/25 | 0.2075 | +13.57% | 685,757 |
24/24/24 | 0.1827 | -5.82% | 815,454 |
23/24/23 | 0.194 | +1.68% | 355,964 |
22/24/22 | 0.1908 | +3.70% | 676,605 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
+27.99% | 10.12M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- GRTX Stock